Upper Respiratory Infections Flashcards
Characteristics of the Rhinovirus
Picornavirus family
- Iscosahedral
- non-enveloped postive sense ss linear RNA virus
Transmission and Pathogenesis of Rhinovirus
- Trasmission:
- person to person
- Respiratory droplets - Pathogenesis
- binds to ICAM-1 on resp. epithelial cells
- ultimately causes release of chemical mediators of inflammation (Bradykinin and prostaglandins)
Clinical manifestations of the Rhinovirus
- Incubation period: 2-4 days
- Sneezing, nasal discharge, sore throat, cough and headache
- Mild chills
- Most common cause of common cold; More in Fall and Winter
Dx and Tx of Rhinovirus
Dx: Clinical
Tx: Supportive care
- no vaccine
Characteristics of the Coronavirus
- Helical, enveloped, positive sense. ss linear RNA
2. Second most common cause of the common cold
Clinical manifestations of the Coronavirus
- outbreaks in winter on a 2-3 year cycle
- Does NOT cause LRTIs (except SARS and MERS)
- Can cause GI illness. But symptoms of common cold are same as Rhinovirus
Characteristics of Bordetella pertussis
- Encapsulated
- Small Coccobacillary Gram Neg. Rod
- A-B toxin (pertussis toxin)
Pathogenesis of Bordetella pertussis
A-B toxin:
B - attaches to host cell surface receptor and enable endocytosis
A - stimulates adenylate cyclase by catalyzing the addition of ADP-ribosylation to the inhibitory subunit of the G-protein
=> overactive cAMP-dependent PK activuty
- impairs phagocytosis and causes dec. cilia activity
Transmission and clinical manifestations of Bordetella pertussis
Transmission: Highly contagious airborne droplets
Clin: Whooping Cough
- Catarrhal stage: 2 wk mild URT symptoms
- Paroxysmal: 2-3 month of severe cough
- Convalescent: 1-2 wks reduction in cough
Dx of Bordetella pertussis
- Nasopharyngeal swab (direct flouro-ab or PCR)
- Culture
- CBC with striking Lymphocytosis
- toxin blocks signal transduction needed for lymphocyte to enter lymph. tissie
* Unique to Bordetella pertussis
Tx of Bordetella pertussis
Azithromycin
- for all individual w/ positive lab Dx
- also for pts with clinical Dx who have had symptoms for
Prevention of Bordetella pertussis
Vaccine (Inactivated toxin)
- Included within the DTaP (diphtheria, tetanus, acellular pertussis)
- given: 2, 4, 6, 15-18 month; 4-6 years; and a booster at age 11
Characteristics of Corynebacterium diptheriae
- GP bacillus
2. Pleomorphic, club-shaped, arranged in palisades, beaded appearance
Pathogenesis of Corynebacterium diptheriae
A-B toxin blocks protein synthesis by inactivating elongating factor 2
- Also induces formation of a pseudomembrane in the throat
Transmission and Clinical manifestations of Corynebacterium diptheriae
Trans: Airborne droplets
- Clin: Gradual onset of…
- Sore throat, that gets progressively worse
- Malaise/fatigue/low-grade fever
- cervical LAD (“bull-neck”)
- Cardiac dysfunction (Myocarditis) 7-14 days after resp onset
- neurotox
- mechanical onstruction